Business
Bruker Reports Third Quarter 2021 Financial Results
Q3 2021 revenues of $608.9 million, up 19.1% year-over-year (yoy); organic growth of 17.8% Q3 2021 GAAP EPS of $0.57, up 63% yoy; non-GAAP EPS of $0.63, up
About this update from Bruker Corporation
[{"type":"text","content":"\n\nQ3 2021 revenues of $608.9 million, up 19.1% year-over-year (yoy); organic growth of 17.8%\n\n\nQ3 2021 GAAP EPS of $0.57, up 63% yoy; non-GAAP EPS of $0.63, up 50% yoy\n\n\nRaising FY 2021 guidance significantly on strong demand for Bruker’s products and solutions\n\n\n BILLERICA, Mass.--(BUSINESS WIRE)--\nBruker Corporation (Nasdaq: BRKR) today announced financial results for its third quarter and for the nine months ended September 30, 2021.\n\nThird Quarter 2021 Financial Results\n\nBruker’s revenues for the third quarter of 2021 were $608.9 million, an increase of 19.1% compared to revenues of $511.4 million in the third quarter of 2020. In the third quarter of 2021, revenues increased 17.8% organically year-over-year, growth from acquisitions was 0.3% and foreign currency translation had a positive effect of 1.0%. In the third quarter of 2021, Bruker continued to see strong, broad-based demand for its products and solutions across its Bruker Scientific Instruments (BSI) Groups and the BEST segment.\n\nThird quarter 2021 GAAP operating income was $113.2 million, compared to $81.2 million in the third quarter of 2020, representing GAAP operating margins of 18.6% and 15.9%, respectively. Non-GAAP operating income was $125.4 million in the third quarter of 2021, compared to $94.9 million in the third quarter of 2020. Bruker’s third quarter 2021 non-GAAP operating margin was 20.6%, compared to 18.6% in the third quarter of 2020. The year-over-year increases in the Company’s GAAP and non-GAAP operating income and operating margins were primarily due to higher revenues and improved gross margins.\n\nThird quarter 2021 GAAP diluted earnings per share (EPS) were $0.57, compared to $0.35 in the third quarter of 2020. Third quarter 2021 non-GAAP diluted EPS were $0.63, an increase of 50% compared to $0.42 in the third quarter of 2020. Higher operating income and a favorable tax rate in the third quarter of 2021 drove growth in GAAP and non-GAAP EPS compared to the third quarter of 2020.\n\nFirst Nine Months of 2021 Financial Results\n\nFor the first nine months of 2021, Bruker’s revenues were $1,734.4 million, an increase of 27.5% from $1,360.0 million in the first nine months of 2020. In the first nine months of 2021, revenues increased 22.6% organically year-over-year. Growth from acquisitions was 0.5%, while foreign currency t...